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Abstract  
Although a growing body of work has shown that behavioural variant 
frontotemporal dementia (bvFTD) could present with severe amnesia in 
approximately half of cases, memory assessment is currently the clinical 
standard to distinguish bvFTD from Alzheimer’s disease (AD). Thus, the concept 
of “relatively preserved episodic memory” in bvFTD remains the basis of its 
clinical distinction from AD and a criterion for bvFTD’s diagnosis. This view is 
supported by the idea that bvFTD is not characterised by genuine amnesia and 
hippocampal degeneration, by contrast to AD. In this multicentre study, we 
aimed to investigate the neural correlates of memory performance in bvFTD as 
assessed by the Free and Cued Selective Reminding Test (FCSRT). Imaging 
explorations followed a two-step procedure, first relying on a visual rating of 
atrophy of 35 bvFTD and 34 AD patients’ MRI, contrasted with 29 controls; and 
then using voxel-based morphometry (VBM) in a subset of bvFTD patients. 
Results showed that 43% of bvFTD patients presented with a genuine amnesia. 
Data-driven analysis on visual rating data showed that, in bvFTD, memory recall 
& storage performances were significantly predicted by atrophy in rostral 
prefrontal and hippocampal/perihippocampal regions, similar to mild AD. VBM 
results in bvFTD (pFWE<.05) showed similar prefrontal and hippocampal regions 
in addition to striatal and lateral temporal involvement. Our findings showed the 
involvement of prefrontal as well as medial/lateral temporal atrophy in memory 
deficits of bvFTD patients. This contradicts the common view that only frontal 
deficits explain memory impairment in this disease and plead for an updated 
view on memory dysfunctions in bvFTD. 
Key words: behavioural frontotemporal dementia, Alzheimer, amnesia, hippocampus 
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Introduction 
Behavioural variant frontotemporal dementia (bvFTD) is the second most 
prevalent type of early onset dementia after Alzheimer’s disease [1]. Despite a 
characteristic behavioural symptomatology, bvFTD could frequently be misdiagnosed 
as AD and, in clinical contexts where amyloid biomarkers cannot be sought, 
clinicians often rely on memory assessment for the differential diagnosis between 
both diseases.  
Episodic memory impairment is indeed the hallmark of typical AD and is not 
contemplated as a possible clinical presentation of bvFTD in the current diagnostic 
criteria [2,3]. However, memory impairments in FTD have been demonstrated 
through many past works. Originally, three of the five patients initially described by 
Arnold Pick suffered from episodic memory disturbances. Additionally, genuine 
amnesia in FTD was consistently observed in the early cases described in the last-
century’s scientific literature as well as in the more systematic observations that 
followed (for a review, see [4]). These findings seem to have been relatively ignored 
until a recent group study reported severe memory impairment in bvFTD [5]. Using 
the Free and Cued Selective Reminding Test (FCSRT) to investigate the different 
memory processes and supporting the patients’ clinical diagnoses with biological 
evidence, a following study showed that half of bvFTD patients could present with a 
genuine amnesia characterized by encoding, storage and consolidation deficits while 
the remaining patients presented a decrease of spontaneous recall that normalized 
with cueing [6]. This identification of two distinct cognitive profiles, namely 
amnestic-bvFTD and non-amnestic-bvFTD [6], has recently been confirmed in an 
independent study [7]. In fact, during the past years, a growing number of studies 
have provided various findings of true memory dysfunctions in bvFTD, with patients 
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having been shown to exhibit a wide range of memory difficulties such as in face 
recognition, object memory [8], prospective memory [9], episodic future-thinking 
[10], autobiographical memory [11], orientation [12], and word-list recall. In 
particular, word-list based memory assessment, the most common form of memory 
evaluation in the field of neurodegeneration, has constantly shown evidence of 
variable memory impairment in bvFTD over the last years. Importantly, this poor 
discrimination power has been shown independently of the test used, such as with the 
Rey Auditory Verbal Learning Test (RAVLT)  [5, 13, 14, 15, 16], the California 
Verbal Learning Test (CVLT)  [17, 18], the FCSRT [6, 7, 19], or others [20].  
Taken together, these findings show that an important overlap between bvFTD 
and AD is consistently observed in neuropsychological studies of memory. The 
recently described bimodal profile of bvFTD patients (i.e. amnestic and non-amnestic 
presentation) explains why mean memory scores can be statistically different between 
AD and bvFTD at a group level (e.g. [19, 21]), but not at an individual level, therefore 
lacking clinical utility in the differential diagnosis of both diseases. 
Beyond the psychometric ability of the FCSRT to distinguish bvFTD from AD 
or not is the topic of its neural correlates in bvFTD. Past structural imaging studies 
have indeed only been conducted in AD [22] or focused on other memory tests [23, 
24, 25, 26]. Despite evidence for bilateral hippocampal atrophy in bvFTD [24, 27, 
28], a common view is still that executive dysfunctions or prefrontal atrophy explains 
memory deficit in bvFTD [29]. Although recently contradicted by data-driven 
evidences [30], this hypothesis has justified the use of the FCSRT to delineate 
executive from genuine memory deficits in bvFTD and AD respectively. However, 
anatomical and neuropsychological data [6, 24, 27, 28, 30] suggest a hippocampal 
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involvement in bvFTD memory dysfunctions as well as the presence of a genuine 
memory impairment.  
This study aims to identify the structural anatomical markers of episodic 
memory impairment in bvFTD as assessed by the FCSRT. Imaging explorations were 
conducted using a two-step procedure. First, a visual rating of the atrophy of 98 scans 
from two centres was conducted in bvFTD, AD and controls, a procedure close to the 
neurological clinical practice. We included a group of AD patients because this 
disease is the most frequent differential diagnosis of bvFTD and because amnesia is a 
clinical characteristic of typical AD. The relationship between atrophy and memory 
performance was then investigated with data-driven methods. Secondly, we used a 
voxel-based morphometric statistical approach in a subgroup of bvFTD patients and 
controls from the same centre.  
 
Methods 
Participants 
A total of 98 participants were included in this study, including 35 probable bvFTD 
patients, 34 patients with AD and 29 healthy aged controls. We included bvFTD 
patients with memory impairment if other core diagnostic criteria were present [3]. 
Patients with bvFTD were selected from the database of the Memory and Alzheimer 
Institute of the Pitié-Salpêtrière Hospital in Paris, France (n=23) and through the 
Cognitive Neurology and Dementia Unit of the Hospital del Salvador, University of 
Chile (n=12). Of these 35 patients who received a clinical diagnosis of bvFTD on the 
basis of clinical, cognitive and imaging examinations (showing evidence of frontal 
and/or temporal atrophy at the MRI and/or hypometabolism at the single-photon 
emission computerized tomography), 31% (n=11) had additional biological evidences 
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supporting the clinical diagnosis through non-AD cerebrospinal fluid measures of 
phospho-tau, total-tau and amyloid-β levels. A group of 35 patients with AD were 
included from the Cognitive Neurology and Dementia Unit (Chile) according to 
McKhann et al. [31] criteria. All underwent a cognitive examination and a T1 MRI. 
One patient was excluded because of significant movement that blurred the MRI 
examination resulting in a group of 34 patients. From an initial sample of 35 controls, 
we retained 29 of them. All were volunteers at the Cognitive Neurology and 
Dementia Unit (Chile). They underwent a neuropsychological examination and a 
MRI. On the basis of these examinations, we excluded 6 controls with abnormal 
cognitive examination or significant vascular signs. All patients were followed for at 
least 12 months and performed another cognitive assessment at 6, 12 or 18 months. 
The clinical progression of the patients included did support the initial clinical 
diagnosis made. All participants underwent a neuropsychological examination, 
assessing memory, executive functions, verbal abilities and attention (see 
supplementary material, Table 2). AD patients underwent the Clinical Dementia 
Rating scale [32]; 14 patients had questionable dementia (CDR=.5), 15 were at a 
moderate stage of the disease (=1) and 5 at a severe stage (CDR=2). CDR data were 
not available for bvFTD patients. 
 
Exclusion criteria included clinically significant vascular lesions (Fazekas scale with 
a score >2). FLAIR sequences were available for all controls, ADs and most of 
bvFTD. For those patients without a FLAIR sequence, we also considered that any 
history of stroke or any sign of infarcts on T1 images were exclusion criteria. In any 
case, the fulfilment of the NINDS-AIREN criteria for vascular disease or the NINDS-
AIREN imaging criteria was an exclusion criterion. Other exclusion criteria were 
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missing cognitive data, concomitant motor-neuron disease, alcoholism, absence of 
T1-MRI or blurred MRI because of significant movements; atypical clinical and 
imaging evolution compatible with the diagnostic of non-progressive bvFTD; atypical 
evolution not in accordance with initial diagnosis (i.e., predominance of language 
impairments, abrupt cognitive deterioration, cognitive improvement or fluctuation).  
 
The Ethics and Scientific Committees of the East Metropolitan Health Service, Chile 
University (Chile) approved the recruitment and testing of participants whom all 
provided written informed consent. Biological and clinical data of French patients 
were collected during the routine clinical workup and were retrospectively extracted 
for the purpose of this study. Thus, according to French legislation, explicit informed 
consent was waived. However, the regulation concerning electronic filing was 
followed, and both patients and their relatives were previously informed that 
individual data could be used in retrospective clinical research. 
 
Assessment of memory 
All participants underwent the Free and Cued Selective Reminding Test (FCSRT), a 
memory test based on a semantic cueing method that controls for effective encoding 
of 16 unrelated words and facilitates retrieval by this semantic cueing. Immediate 
cued recall was tested in a first phase, to control for encoding (Encoding score). Then, 
the memory phase was performed in three successive trials, each trial including a free 
recall attempt (consisting of spontaneous recall of as many items as possible during 2 
minutes) then a cued recall attempt, using an aurally presented semantic category for 
items that were not spontaneously retrieved by the patients. The same semantic cues 
given during the initial encoding stage were used. These phases provided a free recall 
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score and a cued recall score (the sum of both being the total recall score). We 
computed a percentage of sensitivity to cues. Following a delay of 30 minutes, a final 
recall trial was performed, providing free and cued delayed recall scores. The FCSRT 
age, sex and educational level adjusted normative data were considered to classify 
participants as being amnestics or non-amnestics. In more detail, total recall scores 
equal to or below the 10th percentile were considered as abnormal and reflecting a 
genuine amnesia.  
 
Imaging acquisition & analyses 
All participants underwent a whole-brain T1-weighted examination. In Paris, this 
examination was performed with a 1.5 Tesla GE-Medical Systems Signa Excite (n=12 
bvFTD) or with a 3 Tesla GE-Medical Systems Signa HDx (n=11 bvFTD) MRI 
scanners. In Santiago, the examination was performed with a 1.5 Tesla Siemens 
scanner (n=34 AD) or with a 1.5 Tesla Phillips Intera scanner (n=12 bvFTD and 29 
controls). Importantly, as Chilean controls and bvFTD participants underwent the 
examination from the same machine with identical parameters, VBM analyses were 
restricted to these participants. Twenty controls were then selected to match the 
bvFTD participants on age. The 1.5 Tesla Phillips Intera scanner is equipped with a 
standard head coil. A T1-weighted spin echo sequence acquired parallel to the plane 
connecting the anterior and posterior commissures and covering the whole brain was 
used to generate 120 contiguous axial slices (repetition time = 2300 ms; echo time = 
13 ms ; flip angle = 68◦; field of view = rectangular 256 mm ; matrix size = 256 x 240 
; slice thickness = 1 mm; isotropic voxel size 1 × 1 × 1 mm).  
 
Visual atrophy ratings 
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Two raters (EF, MH), blind to the clinical diagnoses, rated T1 coronal MRIs. 
Previously, all textual information displayed on the MR scans was removed and the 
coronal slices were exported into standardized and anonymous video files. The ratings 
of the scans involved reviewing 6 standardized coronal MRI slices: the first one slice 
before seeing the corpus-callosum; the second at the level of the fronto-temporal 
junction; the third posterior to the optical chiasma when the optical nerve are distinct 
and not joined; the fourth at the level of the junction between the Pons and the rest of 
the brain; the fifth at the level where the brainstem is detached from the rest of the 
brain; the sixth one slice after the posterior corpus callosum. A total of 11 regions 
were scored bilaterally; on the first slice the dorso-lateral, medial and ventro-median 
prefrontal cortices; on the second slice the anterior cingulate and polar temporal 
cortices; on the third the amygdala as well as the perirhinal and enthorinal cortices; on 
the fourth, the anterior hippocampus; on the fifth, the posterior hippocampus; on the 
sixth, the precuneus. Atrophy within each region was rated on a 5-point Likert scale 
ranging from 0 to 4 (0=normal; 1=borderline appearances, possibly normal; 
2=definite atrophy present; 3=marked atrophy; 4=severe atrophy). The raters were 
first trained (two sessions) on an independent set of 29 MR scans that included 
different dementia populations with varying degrees of severity, as well as healthy 
controls. Inter-rater reliability between the two raters was assessed through inter-class 
correlation. Coefficients were significant and good (average Cronbach’s alpha = 
0.744). 
 
Statistics 
Using SPSS 20 (SPSS, Chicago, IL, USA), one-way ANOVA were conducted to 
compare demographic, neuropsychological and imaging data across groups (with age 
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as a covariate for the two last dimensions), followed by Bonferroni post hoc tests. 
Binary logistic regressions with Enter method were computed for atrophy ratings. As 
a second step, all brain regional ratings were entered into an Automated Linear Model 
(ALM) as predictors of FCSRT Free recall and total recall scores separately. 
Basically, in a heterogeneous group of potential predictor variables, ALM will find 
the best way to predict targeted values on a single scaled outcome variable. ALM 
overcomes the limitations of traditional regression techniques [33] and involves 
automatic data preparation and variable selection.  
 
Voxel based morphometry analyses 
These analyses were performed on 3D T1-weighted sequences that were acquired 
with the same machine in Santiago, Chile. Images were analysed with FSL-voxel 
based morphometry (VBM), a VBM analysis [34, 35] which is part of the FSL 
software package (http://www.fmrib.ox.ac.uk/fsl/fslvbm/index.html) [36]. First, tissue 
segmentation was carried out using FMRIB’s automatic segmentation tool (FAST) 
[37] from brain-extracted images. The resulting grey-matter partial volume maps were 
then aligned to the Montreal Neurological Institute standard space (MNI152) using 
the non-linear registration approach using FNIRT [38, 39], which uses a b-spline 
representation of the registration warp field [40]. Default settings were used for these 
steps, but quality control for each scan was performed and slight alteration of the 
search space for the segmentation algorithm was performed for some patients with 
severe atrophy. A study specific template was created in which bvFTD and control 
participants were equally represented, following which the native grey matter images 
were re-registered non-linearly to this template. The registered partial volume maps 
were then modulated (to correct for local expansion or contraction) by dividing them 
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by the Jacobian of the warp field. Importantly, the Jacobian modulation step did not 
include the affine part of the registration, which means that the data are normalized 
for head size as a scaling effect [41]. The modulated images were then smoothed with 
an isotropic Gaussian kernel with a SD of 3 mm. 
 
VBM analyses were conducted on 20 controls and 12 bvFTD patients who did not 
differ on age (68.85 and 68.27 years respectively, p>.84) and education level (13.55 
and 13.67 years respectively, p>.95). VBM analyses were run on a subsample of 
participants that had the same imaging protocol, as a validation of the visual ratings of 
regional atrophy. AD patients were not included in these analyses because the 
acquisition of the MRI for those patients was performed with a different machine. 
 
A voxel-wise general linear model (GLM) was applied and permutation-based non-
parametric testing was used to form clusters with the Threshold-Free Cluster 
Enhancement (TFCE) method [42], tested for significance at p<.05, corrected for 
multiple comparisons via Family-wise Error (FWE) correction across space. Age was 
added as a nuisance variable in the GLM.  
 
First, a two-sample t-test was run to contrast patients and controls in order to identify 
specific regions atrophied in patients. Then, we performed a correlation analysis 
between grey matter intensity and FCSRT scores in bvFTD only (using a specific 
template with bvFTD patients only). Each FCSRT score was entered as a covariate of 
interest in the GLM. For statistical power, a covariate only statistical model with a 
positive t-contrast was used, providing an index of association between grey matter 
intensity and performance on the FCSRT. Anatomical locations of significant results 
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were overlaid on the MNI standard brain. Anatomical labelling was determined with 
reference to the Harvard-Oxford probabilistic cortical atlas. 
 
Results 
Demographics and clinical data (Table 1) 
Control participants did not differ from AD and bvFTD on age (all p’s>.05) but AD 
patients were significantly older than bvFTD patients (p=.001). The three groups did 
not differ on education level. MMSE performance followed an expected profile with 
controls scoring significantly higher than bvFTD patients (p<.001) who in turn scored 
significantly higher than AD patients (p=.001). In addition, the neuropsychological 
assessment revealed an impairment of abstract reasoning, cognitive inhibition, 
attention and verbal fluency abilities in both AD and bvFTD (see Supplementary 
Material, Table 2 for more details).  
 
Episodic memory impairment (Table 1) 
FCSRT scores showed that controls performed significantly better than bvFTD (all 
p’s<.05) except for the encoding score (p=.626). However, bvFTD performed 
significantly better than AD (all p’s<.001) on all scores (free recall, total recall, 
sensitivity to cues and delayed recall), except encoding score. 
When taking the FCSRT normative data to identify amnestic patients, 85% of AD and 
43% of bvFTD were considered to be amnestic. There was no difference in the 
proportion of amnestic patients in the Chilean and French subgroups (41.7% and 
43.5% respectively). Interestingly, when considering the FCSRT thresholds originally 
proposed to identify the “amnestic syndrome of the medial temporal type” [43], we 
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obtained a strict identical classification of patients. Mean percentile rank and 
ranges are available on Table 3 (Supplementary Material). 
 
Regional atrophy, visual ratings (Figure 1) 
Raters’ average scores of atrophy for each region were compared across the groups. 
When considering the three groups, the ANOVA showed significant differences in all 
brain regions rated (all p’s<.05). Post-hoc two-by-two Bonferroni comparisons were 
then performed. Compared to controls, AD showed more atrophy in all regions (all 
p’s<.05) with the exception of the left dorsolateral prefrontal cortex. Compared to 
controls, bvFTD showed more atrophy in all regions (all p’s<.05) except in the 
bilateral dorsal prefrontal cortex and in the left precuneus, where only statistical 
trends were observed. 
AD had more atrophy than bvFTD in the left anterior (p=<.005; Cohen’s d=.096) 
hippocampus and in the left and right posterior hippocampus (p=.008; d=.126 and 
p=.01; d=.039 respectively). These effect-sizes were small. However, bvFTD had 
more atrophy than AD in the right ventro-median (p=.01; d=.626) and right medial 
prefrontal cortices (p=.0001; d=.949). By contrast, these effect-sizes were medium 
and large. 
 
Logistic regressions were conducted on the raters’ average scores of atrophy in the 
regions identified during the direct comparison between bvFTD and AD. The left 
anterior hippocampus reached an accuracy of 66.7% to predict the correct diagnosis 
of patients (ie. AD identified as AD and bvFTD identified as bvFTD). The right 
anterior and posterior hippocampus reached an accuracy of 62.3% and 63.8% 
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respectively. In the frontal regions, the right OFC and the right mPFC reached an 
accuracy of 66.7% and 69.6% to predict the correct diagnoses. 
 
Automated Linear Model  
In this step, all brain regional ratings were entered into an ALM aiming to identify the 
significant predictors of FCSRT free recall and total recall scores separately. One 
separate ALM was run for each patients group. 
 
FCSRT Free Recall 
In AD, the model reached an adjusted R2 of 49.5% with an information criterion of 
130.799 and identified the bilateral medial prefrontal cortex as a significant predictor 
of the FCSRT Free Recall score, although this result failed to survive after correction 
for multiple comparisons. 
In bvFTD, the model failed to identify any significant predictor. 
 
FCSRT Total Recall 
In AD, the model reached an adjusted R2 of 27% with an information criterion of 
169.822 and identified the bilateral mPFC and the left dorsolateral as significant 
predictors of the FCSRT total recall score but these regions failed to remain 
significant after correcting the model for multiple comparisons. In addition, a visual 
inspection of the linear regression plot between predicted and actual values showed 
two separate subgroups corresponding to patients with severe amnesia (FCSRT total 
recall <20) and patients with moderate amnesia (FCSRT total score >20). A linear 
curve was only evident in the last subgroup. We then decided to distinguish AD 
patients as being in the mild or moderate/severe stage of the disease using the GDS as 
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an independent criterion and ran the ALM again on the AD subgroups identified by 
the GDS score separately. In the mild AD group (N=14), the model reached an 
adjusted R2 of 96.9% with an information criterion of 46.802 and identified the left 
amygdala, the right OFC, the left mPFC, the left perirhinal and enthorinal cortices and 
the right posterior hippocampus as significant predictors. All these regions remained 
significant after correction. In the moderate/severe AD group (N=20), the model 
failed to identify any significant predictor. 
In bvFTD, the model reached an adjusted R2 of 59.9% with an information criteria of 
150.915 and identified the bilateral perirhinal cortex, the bilateral OFC, the left 
anterior hippocampus, the right posterior hippocampus and the left mPFC as 
significant predictors of the FCSRT total recall score. After correction, the left 
perirhinal and right ventro-median cortices as well as left anterior hippocampus 
remained significant. 
 
Voxel based morphometry (Figure 2 & 3) 
All VBM results were obtained at a threshold of p<.05 after FWE correction. We only 
report clusters with a conservative cluster extent threshold of 100 contiguous voxels. 
Peak coordinates, cluster sizes and t-values for each result are reported in Table 4 
(Supplementary Material). Comparison between bvFTD and controls showed an 
important cluster (66148 voxels) encompassing large parts of the dorsal and ventral 
medial frontal cortex, regions of the dorsolateral frontal cortex, anterior and posterior 
insula, most of the regions of the striatum, the thalamus, polar regions of the temporal 
lobe, middle temporal gyrus, amygdala and hippocampus bilaterally as well as regions 
within the parietal and occipital lobe, mostly lateralized on the right side and a 
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bilateral involvement of the cerebellum. Another large cluster (1693 voxels) was also 
found in the right cerebellum.  
 
Correlation with FCSRT Free Recall in bvFTD 
Results showed two clusters (266 and 138 voxels respectively) in the left middle 
temporal gyrus. 
 
Correlation with FCSRT Total Recall in bvFTD 
A large cluster (19498 voxels) correlated with the FCSRT total recall score and 
encompassed the ventral mPFC in its subgenual portion, the anterior putamen and 
nucleus accumbens within the striatum, the insula, large parts of the polar and lateral 
regions of the temporal lobes bilaterally, bilateral median cerebellum (regions V, IX, 
vermis VIII), bilateral lateral cerebellum (regions VI and Crus I) as well as the left 
amygdala, anterior hippocampus, perihippocampus and ventral temporal regions. 
 
Correlation with FCSRT Sensitivity to cueing in bvFTD 
Sensitivity to cueing correlated with a first cluster (6874 voxels) within the right 
temporal lobe including the right polar temporal regions extending to the anterior 
portion of the superior temporal gyrus and to large parts of the middle temporal gyrus. 
This cluster also included posterior portions of the inferior temporal gyrus (including 
its most ventral parts) as well as right putamen and amygdala. A second cluster (3466 
voxels) was found in the left temporal lobe encompassing the temporal pole in its 
superior regions, anterior and posterior regions of the inferior temporal gyrus, 
posterior regions of the middle temporal gyrus and the left amygdala and 
hippocampus. 
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Correlation with FCSRT Delayed Total Recall in bvFTD 
Delayed total recall score correlated with a large cluster (22788 voxels) that was 
highly similar to the cluster identified with the correlations with FCSRT Total recall 
score. The same regions were involved, with ventral prefrontal regions extended more 
anteriorly, beyond the sole subgenual cortex. 
 
Discussion 
The main goal of the study was to identify, in bvFTD, the structural grey-
matter correlates of episodic memory dysfunctions as measured by the FCSRT. Past 
neuroimaging studies in the field did rely on other memory tests, which are different 
in their construct as they do not allow to control for encoding or to delineate free and 
cued recalls. To our knowledge, only one previous imaging study did investigate the 
neural correlates of FCSRT scores in bvFTD but through metabolic imaging [7].  
In accordance with previous works [6, 7, 28], we first observed that 40% of 
bvFTD patients had abnormal memory performance characterized by poor retrieval, 
decreased storage abilities and low sensitivity to semantic cues. The imaging results 
showed a lateral temporal involvement related to the free recall score of the test, a 
large fronto-insulo-striato-cerebello-temporal correlation with FCSRT’s total and 
delayed total recall scores, and a lateral-polar temporal involvement related to the 
sensitivity to semantic cues during the test. In more detail, the bilateral ventro-median 
prefrontal cortex (vmPFC), the left hippocampus, left perihippocampal regions and 
the bilateral temporal poles in bvFTD showed a significant relationship with the total 
and delayed total recall of the FCSRT, two measures of memory storage and 
consolidation. By contrast, regions identified in mild AD were the left amygdala, right 
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vmPFC, left mPFC, left anterior perihippocampal regions and the right posterior 
hippocampus. These regions were identified during the first step of our study, based 
on a visual rating of each patient’s scan atrophy, blinded to diagnosis. In this step, all 
measures of atrophy were entered in an automated linear model (ALM) used to 
identify the key regions that significantly predicted the FCSRT total recall 
performance in each group. In a second step, VBM correlation analyses with FCSRT 
performance in bvFTD identified the same regions as the ALM did, alongside a larger 
fronto-insulo-temporal network.  
 
In contradiction with the common conception that memory deficits in bvFTD 
are solely attributed to prefrontal dysfunctions, the correlation between the degree of 
hippocampal atrophy and memory storage/consolidation deficits was highly expected 
in our study. Many converging works have indeed shown the role of these regions 
during encoding and consolidation of episodic memories [see 44] and atrophy of the 
left hippocampus in particular has been found to correlate with the FCSRT total recall 
score in AD [22]. Here we show that, similarly to what is observed in AD, the atrophy 
of the hippocampal/parahippocampal regions is involved in the true memory deficit 
observed in bvFTD.  
Another region identified in our results is the vmPFC. Although its role in 
autobiographical memory is well know, especially for emotional or self-related items 
[45, 46], its role in episodic memory as assessed by word-list based tests remains 
unclear. This region is richly interconnected with multiple structures within the Papez 
circuit as well as limbic and paralimbic regions involved in memory processing [47]. 
Its connections with the temporal pole via the ventral branch of the uncinate fascicle 
are of crucial interest in the context of memory retrieval. This regional combination 
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was found to trigger the retrieval of episodic and factual events [48, 49] and OFC was 
specifically found to be of critical usefulness during the encoding phase and for 
applying organizational strategies during the retrieval phase of the CVLT [50]. One 
interesting interpretation could nicely explain the involvement of the vmPFC during 
the FCSRT retrieval phases. A recent lesion study showed that impairment of 
mnemonic monitoring and control was associated with lesions of the subcallosal 
segment of the vmPFC, the same region found in our VBM results [51]. According to 
these authors, similarly to the way valuation mechanisms integrate various aspects of 
a choice into a single subjective value, mnemonic monitoring processes integrate 
information to subjectively assess the likelihood of a memory being correct or not. 
Our findings could thus reflect a critical involvement of the atrophy of this region to a 
failed or imperfect second-order confidence, choice or answer [51]. In other words, 
the correlation between the vmPFC and FCSRT measures could represent a failed 
judgement about the accuracy of the given answers related to the semantic cues. 
The atrophy of the temporal pole was also correlated to storage and 
consolidation deficits in our study. Similarly to the vmPFC and hippocampus, this 
region was already found to be covaried with memory performance in bvFTD [16] as 
well as in AD [52]. Clinically based investigations as well as computational models 
strongly support the critical role of the temporal pole in semantic cognition, acting as 
an amodal “semantic hub” [53]; however, the role of the temporal pole in verbal 
memory processing is far less known. Its involvement in episodic memory could only 
be indirectly suggested by prior studies that have shown how semantic impairment 
may contribute to deficits in verbal episodic memory or during learning (e.g [54, 55]). 
One recent work has however showed a direct link between temporal pole and 
episodic verbal memory by showing the impact of temporal pole lesion in false 
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memory [56]. In more detail, this study demonstrated that the temporal pole contains 
partially overlapping neural representation of related concepts, with the extent of this 
neural overlap reflecting the semantic similarity between those concepts. As the 
FCSRT total recall depends on the ability to rely on a given semantic cue (e.g. 
profession) to retrieve a previously learned word (e.g. plumber), it is easy to 
understand that providing a semantic cue could open the door to false memories 
which are closely related to the same semantic concept (e.g. electrician), thus 
explaining the correlation between temporal pole’s atrophy and the FCSRT total 
recall score decrease as well as the decrease of sensitivity to semantic cues. Further 
qualitative studies analysing the type of errors committed during memory testing by 
patients could help to confirm that the same mechanism is indeed at play in this 
context. 
Among the other regions involved in memory deficits in bvFTD, our analyses 
identified the lateral temporal regions, insula and cerebellum that were correlated to 
memory storage and consolidation performance. Strong evidence suggests that lateral 
temporal regions are also involved in semantic processing and that this region carries 
the neural representation of concrete words in particular [57]. Investigations related to 
the role of the insula in verbal memory are rare and further studies are needed to fully 
understand its role in memory processing. Although our data cannot directly address 
this question, Mesulam & Mufson [58] suggested that insular connections provide a 
critical anatomical substrate for memory functions and lesion data have supported this 
assumption [59]. Median and lateral subregions of the cerebellum have already been 
found to correlate with memory performance (and other cognitive functions) in 
bvFTD [60] with lobules VII and the vermis emerging as specific correlates to 
memory deficit. These results support the concept of a cortical-cerebellar network to 
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support memory processing in bvFTD [61] and highlight the necessity to investigate 
further the cerebellar contribution in cognitive processing.  
 
Although this study is the first to investigate the structural grey-matter 
correlates of the FCSRT performance in bvFTD, a recent study focused on the 
metabolic correlates of this test is of particular interest [7]. To our knowledge, this 
study was the only previous imaging study focused on FCSRT performance in bvFTD 
and it reported that FCSRT total recall score was correlated with lower metabolism in 
bilateral inferior temporal gyri, right uncus and right parahippocampus gyri. The same 
regions (minus parahippocampal regions) were found to be correlated to the total 
delayed recall score. Interestingly, this study did not report any metabolic correlates 
in the vmPFC or hippocampus. This absence of result could be due to the inclusion of 
the MMSE as a covariate, which integrate items assessing memory encoding/retrieval 
and is also correlated to disease severity. However, the involvement of these two 
regions together with the temporal pole was reported in virtually all previous 
structural studies of memory performance in bvFTD, using visual rating scale of 
atrophy [23, 62], VBM correlation analyses [16, 25, 26] or VBM contrast in bvFTD 
patients between high and low memory impairment [24], in addition to imaging 
studies reporting hippocampal degeneration in bvFTD [27, 63, 64]. Taken together, 
these metabolic and structural findings, including ours, highlight the impact of medial 
prefrontal and medial/lateral temporal alterations on memory impairments in bvFTD. 
 
The small sample size of the VBM analysis could limit the interpretation of 
our findings. In addition, the direct contrast between bvFTD and AD groups in VBM 
has not been investigated because each group was examined with different scanners 
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and the design of our study did not allow the use of statistical procedures that could 
control for this bias. Although VBM analyses conducted specifically in the AD 
subgroup identified FCSRT total recall’s correlates in the hippocampi, retrosplenial 
and subcallosal cortices, this result was only obtained at an uncorrected threshold and 
needs to be replicated in larger sample. Further studies should replicate our findings 
in a larger sample, ideally with biological data that could support the clinical 
diagnoses of the patients. These data were not available for the majority of our 
patients, and thus we cannot rule out that some bvFTD patients had an underlying AD 
pathology (or that some AD patients had FTLD pathology). In addition, future studies 
should employ diffusion tensor imaging procedures to investigate the white matter 
tracts that could be degenerated in bvFTD and impact memory performance in this 
disease. Our study suggest that, given the role of vmPFC and temporal limbic 
structures in memory deficits, the uncinate fasciculus, connecting these structures 
together, could be a good candidate for a region of interest approach. Another 
limitation is that this study did not take into account the use of medication that could 
impact cognition in patients. Although this limit is common to most of the studies in 
the field, studies that specifically address this question should be conducted to 
investigate this possible pharmacological impact. Finally, the absence of FLAIR 
sequence for all participants may have led to the inclusion of patients with vascular 
impairment although our exclusion criteria may have restrained this limit. 
Despite these limitations, the good consistency between visual ratings of 
atrophy and VBM analyses (both relying on results corrected for multiple 
comparisons) support the validity of our results. This study thus has important 
implications for the understanding of memory deficits in bvFTD. In this study, we 
showed evidences that memory storage functions could be genuinely impaired in 
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bvFTD and that hippocampal, perihippocampal, temporal and vmPFC regions were 
found to correlate with these deficits. In line with a recent data-mining cognitive 
study [30], this contradicts the common view that executive dysfunctions (and thus 
atrophy in dorsal/cingulate frontal regions) solely cause memory deficits in bvFTD. 
Another important impact of this study is related to the diagnostic criteria of bvFTD 
and AD. The well-established link between hippocampus atrophy and FCSRT storage 
difficulties has driven the conceptualisation of the “amnestic syndrome of the 
hippocampal type” that have been proposed to specifically help the diagnosis of 
typical AD [2]. By contrast, the “relative preservation of episodic memory” is 
included in the revised diagnosis criteria for bvFTD [3]. We believe that our results, 
taken with the growing number of studies that showed a significant proportion of 
bvFTD patients presenting patent episodic memory impairments are now blurring the 
line between AD and bvFTD and their clinical distinction [5, 6, 7, 15, 18, 24, 25, 26, 
28, 30]. Despite their usefulness, there is thus a necessity to revise the current 
diagnostic criteria for bvFTD given the important proportion of amnestic-bvFTD 
presentation. Future studies on this topic should also review each bvFTD patients’ 
clinical profile and symptoms in order to check their compatibility with the current 
revised criteria; data that were not available in the present study.  
Furthermore, this study also highlights that current neuropsychological tests of 
memory functioning may not be appropriate neither to identify the impaired 
processes, nor to distinguish one disease from another, as it was previously thought. 
For example, the FCSRT’s free recall has long been considered as a measure of 
executive processing of memory retrieval, by contrast to total recall, considered as a 
purest measure of memory storage. However, this study and others did not retrieve 
any evidences supporting this assumption (e.g. [16, 30]). Also, beyond the group 
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differences that can be statistically observed (e.g. [21]), individual performances show 
how poor the accuracy of the FCSRT is to distinguish bvFTD from AD because of the 
significant proportion of amnestic-bvFTD patients [6, 7]. Finally, we believe that 
word-list based memory assessments are not ecologically valid and should be 
replaced by tasks more closely related to everyday activities. They have been 
considered as a useful proxy to assess episodic memory but their “episodic” character 
is only assumed and lacks support of evidence. Episodic recollection is supposed to 
imply autonoetic consciousness [65], but this ability is not measured in word-list 
based tasks and thus, these tests do not comply with this “episodic” criterion [65, 66]. 
In addition, no real-life situations involve learning and retrieving 16 unrelated words, 
which is in stark contrast to more ecological paradigms developed recently such as the 
supermarket task [67] that may have a real potential. Current memory tests such as the 
RAVLT, FCSRT or CVLT also involve a strong language component and are thus 
difficult to use or to interpret in context of aphasia. Beyond memory assessment, our 
group and others have shown that social cognition has good potential to distinguish 
bvFTD from AD, even when both diseases present with a severe amnesia [68], as it 
critically involves the mPFC [69, 70], a region selectively atrophied in bvFTD. 
Supporting this view, our imaging results show that the mPFC was the region 
providing the better distinction accuracy between bvFTD and AD. Social cognition 
may thus be the most interesting cognitive domain to explore as it could provide key 
elements for the distinction between both diseases. 
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 Controls  
(n=29) 
AD  
(n=34) 
bvFTD  
(n=35) 
Demographics & clinical data 
Age (years) 71.72 (5.8) 74.11 (6.7) § 67.17 (9.3) § 
Education (years) 12.86 (4.0) 10.79 (4.8) 12.14 (5.2) 
MMSE 28.28 (1.5) *, ¶ 21 (4.7) ¶, § 24.23 (3.9) *, § 
Episodic memory assessment (FCSRT) 
Encoding (/16) 15.14 (0.9) *, ¶ 9.29 (4.4) ¶ 14.35 (2.3) * 
Free recall (/48) 28.35 (6.6) *, ¶ 8.06 (6.77) ¶, § 16.83 (8.06) *, § 
Total recall (/48) 44.86 (3.4) *, ¶ 22.26 (13.2) ¶, § 37.74 (11.4) *, § 
Sensitivity to cues (%) 85.45 (14.1) *, ¶ 39.08 (26.0) ¶, § 71.06 (26.5) *, § 
Delayed total recall (/16) 15.34 (0.9) *, ¶ 6.18 (5.0) ¶, § 12.77 (4.1) *, § 
Amnestic participants (%) 0% 85% 43% 
 
Table 1 – Demographics, clinical and memory performances for controls, AD and 
bvFTD patients and percentage of amnestic participants according to the FCSRT 
normative data. Mean (Standard deviation). MMSE=Mini Mental State Examination; 
FCSRT=Free and Cued Selective Reminding Test. *= Significant difference (p<.05 
corrected) between bvFTD and controls; §= Significant difference (p<.05 corrected) 
between AD and bvFTD; ¶= Significant difference (p<.05 corrected) between AD and 
controls. 
 
 
 
 
 34 
Figures  
 
 
 
Figure 1 – Graphic representation of the differences (and error bars) between AD 
(grey) and bvFTD (black) patients and controls atrophy (taken as a baseline) in all left 
and right regions of interest. Asterisk represent either AD>bvFTD (grey) or 
bvFTD>AD (black) significant difference (corrected for multiple comparison). Ant= 
anterior, Post=posterior. PFC=prefrontal cortex. 
 
 
 
 
 
 
 
 
 
Figure 2 – Atrophy observed in the bvFTD group, resulting from the VBM contrast 
between controls and bvFTD patients at pFWE<.05 (controlled for age). 
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Figure 3 – Results of the correlation between grey-matter intensity in bvFTD and 
FCSRT Free (red), total (blue) and delayed total (yellow) recall scores as well as 
sensitivity to cueing (green) at pFWE<.05 (with age as a nuisance variable). MNI 
coordinates (x, y, z) are specified for each pair of views (coronal and sagittal). 
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Supplementary material 
 
1 - Neuropsychological assessment 
Table 2 – Neuropsychological performance of control participants and patients. Mean 
(SD). N.A: Non available. mWCST: modified Wisconsin Card Sorting Test (Neslon, 
1976). 
 
 Controls  AD bvFTD  
mWCST Category (/6) 4.9 (1.3) 2.6 (1.7)  3.4 (1.8)  
mWCST Perseveration errors 3.9 (4.4) 11.6 (6.7) 6.5 (5.2) 
mWCST Attention errors 1.6 (4.4) 4.1 (3.1) 2.3 (3.1) 
Lexical verbal fluency 15.8 (5.5) 8.7 (3.9) 8.1 (6.3) 
Category verbal fluency 19.8 (5.8) 9.8 (4.9) 12.0 (5.5) 
Digit Span Forward 5.6 (1.1) 4.5 (1.1) 5.2 (1.1) 
Digit Span Backward 4.0 (1.1) 3.1 (1.0) 3.3 (0.9) 
Picture naming (100%) 88.8 (10.2) N.A. 81.4 (14,6) 
 
Non-parametrical Kruskal-Wallis test was used to identify differences between the 
three groups. For all neuropsychological tests, significant differences (all p’s<.005*) 
were observed. Two-by-two differences were then investigated through Mann-Whitney 
test. Compared to controls, both AD and bvFTD patients showed a significantly lower 
mWCST category, verbal fluencies and digit span scores and a significantly higher 
number of perseveration and attention errors (all p’s<.005*). Compared to bvFTD 
patients, AD patients had a lower digit span forward score (p<.05), a higher number of 
perseveration (p<.005*) and attention (p<.05) errors at the mWCST. * indicates results 
corrected for multiple comparisons. 
 
References 
Nelson HE (1976). A modified card-sorting test sensitive to frontal lobe defects. 
Cortex 12:313–24.  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2 - Free and Cued Selective Reminding Test 
Table 3 – Mean percentile rank (percentile ranges) for the participants at the FCSRT. 
 Controls  AD  bvFTD  
Encoding  74.5 (46.5 – 87.8) 16.5 (0.6 – 87.8) 54.1 (8.1 – 87.8) 
Free recall  79.6 (38.8 – 99.5) 26.5 (3.1 – 86.7) 51.0 (3.1 – 86.73) 
Total recall  65.3 (44.9 – 95.9) 23.5 (1.5 – 85.7) 42.9 (0.5 – 85.7) 
Sensitivity to cues  69.4 (28.6 – 95.9) 24.49 (2.04 – 87.8) 47.9 (0.5 – 87.8) 
Delayed total recall  72.5 (40.8 – 86.2) 21.4 (3.1 – 63.8) 43.9 (3.1 – 86.2) 
 
3 - VBM Results 
 
Table 4 – Peak voxels coordinates (in mm – MNI space), labels, clusters size and 
t-values for the results of the VBM correlation in bvFTD 
 Peak voxel coordinates 
(mm) 
Peak voxel labels (Harvard-
Oxford atlas in FSL). 
Cluster 
size 
t-values 
 Contrast between bvFTDs and Controls 
Atrophy in bvFTD 14 -18 0 Right thalamus 66148 5.2666 
26 -74 -56 Right cerebellum 1693 3.3749 
 Correlation with FCSRT scores 
Free Recall -68 -24 -18 Left middle temporal gyrus 266 2.0996 
-64 -44 -16 Left inferior temporal gyrus 138 2.0788 
Total Recall -44 -8 -46 Left anterior portion of the 
inferior temporal gyrus 
19498 3.3749 
Sensitivity to cueing 48 -50 -28 Right inferior temporal 
gyrus 
6874 3.2094 
-46 -6 -46 Left inferior temporal gyrus 3466 2.4528 
Delayed Total Recall -44 -8 -46 Left inferior temporal gyrus 22788 3.3749 
